What is the maximum dose of propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Propranolol

The maximum dose of propranolol varies by indication: 640 mg/day for hypertension and angina, 480 mg/day for migraine prophylaxis, 320 mg/day for angina in some guidelines, and 3 mg/kg/day for pediatric infantile hemangiomas. 1, 2

Adult Maximum Dosing by Indication

Hypertension

  • The FDA-approved maximum dose is 640 mg/day for hypertension, though the usual maintenance dose is 120-160 mg once daily with extended-release formulations 1
  • Clinical trials have demonstrated safety and efficacy up to 640 mg/day when added to diuretic therapy, with dose-response curves flattening after 160 mg in most patients 3

Angina Pectoris

  • The American College of Cardiology states that doses up to 480 mg/day have been used, though some practitioners claim benefit with massive doses up to 1,000 mg/day—a practice not generally accepted 2
  • The FDA label indicates that safety of dosages exceeding 320 mg/day has not been established for angina 1
  • Research demonstrates that optimal therapeutic benefit in angina typically occurs at 144 mg/day (average), though individual patients may require up to 480 mg/day for maximal effect 4
  • For most patients with angina, the average optimal dosage is 500-800 mg/day, similar to or higher than doses used for hypertension 5

Hypertrophic Cardiomyopathy

  • Doses up to 480 mg/day are recommended, with some investigators reporting use of massive doses up to 1,000 mg/day, though this is not standard practice 2

Migraine Prophylaxis

  • The maximum dose is 240 mg once daily with extended-release formulations 1
  • If adequate response is not achieved within 4-6 weeks at maximum dose, propranolol should be discontinued 1

Ventricular Arrhythmias

  • Doses up to 960 mg/day have been studied for suppression of chronic ventricular arrhythmias, with effective plasma levels ranging from 12-1,100 ng/ml 6
  • Only one-third of patients respond at doses ≤160 mg/day, but an additional 40% respond with doses of 200-640 mg/day 6

Pediatric Maximum Dosing

Infantile Hemangiomas

  • The maximum dose is 3 mg/kg/day divided into 2-3 doses for uncomplicated infantile hemangiomas 2, 7
  • For children with comorbidities (hyperinsulinism, preterm birth, low weight), more cautious dosing schedules are required with individualized regimens 2
  • For suspected PHACES syndrome, the starting dose is lower (0.5 mg/kg/day) until brain imaging is completed 2

General Pediatric Use

  • The standard maximum is 2 mg/kg for children in cardiovascular indications 2

Critical Dosing Principles

Dose Titration Strategy

  • Start at low doses (80 mg/day for adults, 1 mg/kg/day for pediatrics) and increase gradually at 3-7 day intervals until optimal response is achieved 1, 2
  • Titrate to clinical endpoints (heart rate 55-60 bpm, symptom relief, or side effects) rather than fixed maximum doses 5
  • The dose-response relationship shows progressive benefit with logarithmic dose increases, though curves flatten at higher doses 5, 3

Monitoring at Higher Doses

  • Monitor for hypotension, bradycardia, and signs of excessive beta-blockade (dizziness, extreme fatigue, syncope) especially during dose escalation 7, 8
  • Heart rate and blood pressure should be assessed before each dose increase 7

Safety Considerations at Maximum Doses

  • The greatest risk of precipitating heart failure occurs when initiating therapy, not at higher doses, provided increases are gradual 5
  • Side effects at very high doses (640 mg propranolol) include fatigue and other beta-blocker effects, though minimal side effects were noted in comparative trials 3
  • Never abruptly discontinue propranolol after chronic use at any dose—taper gradually over several weeks to prevent rebound hypertension, tachycardia, or angina 7, 8

Common Pitfalls

  • Assuming all patients respond at standard doses—many require higher doses for optimal effect, particularly in angina and arrhythmias 5, 6
  • Using fixed low doses when dose titration to clinical endpoints would provide superior outcomes 5
  • Failing to recognize that plasma propranolol levels vary widely between patients at the same dose, making dose individualization essential 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Propranolol in the treatment of angina: a review.

Postgraduate medical journal, 1976

Guideline

Propranolol Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.